ArticlePloS one2011

Recombinant VP1, an Akt inhibitor, suppresses progression of hepatocellular carcinoma by inducing apoptosis and modulation of CCL2 production.

Tai-An Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.